Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Epizyme, Inc.

NASDAQ: EPZMHealthcare / Biotechnology / USA
11.72-0.5000-4.09%Vol 419 8541Y Perf -32.39%
Feb 21st, 2019 16:00
BID11.72 ASK11.73
Open12.16 Previous Close12.22
Pre-Market- After-Trading11.72
 - -%  - -%
Target Price
18.38 
Analyst Rating
Strong Buy 1.25
Potencial %
56.83 
Finscreener Ranking
★★★★★     63.63
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
★★★★     60.23
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)928 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
40.47 
Earnings Date
12th Mar 2019

Today's Price Range

11.6712.20

 

52wk Range

5.1421.40

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
28.09%
3 Months
67.43%
6 Months
5.11%
1 Year
-32.39%
3 Years
22.72%
5 Years
-61.02%

Quotes

Name / TickerPriceChg.Chg.%
EPZM11.72-0.5000-4.09
AAPL171.06-0.9700-0.56
GOOG1 096.97-16.8300-1.51
MSFT109.412.26002.11
XOM77.82-0.7100-0.90
WFC49.56-0.2500-0.50
JNJ135.42-0.9300-0.68
FB160.04-2.5200-1.55
GE10.03-0.0700-0.69
JPM105.47-0.2200-0.21
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
7.20
Current Ratio
7.50
Long Term Debt to Total Capital
0.00
Total Debt to Equity
0.00
Interest Coverage
-
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-1 176.30
EBITDA Margin
-1 166.20
Pre-tax Profit Margin
-1 874.60
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
5.82
PS Ratios
82.27
Price to Cash Flow
25.60
Price to Free Cash Flow
-10.10
Cash Flow Per Share
-1.86
Price to Tangible Book
5.82
Book Value per Share
2.17
Enterprise Value (in ths.)
819 178
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-60.92
ROE last 12 Months
-62.59
Return on Assets (5Y Avg)
-34.55
ROA last 12 Months
-52.59
Return on Capital (5Y Avg)
-60.61
ROC last 12 Months
-62.15
Return on invested Capital Q
-19.86
Return on invested Capital Y
-61.36
Assets Turnover
0.00
Receivables Turnover
1.90
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
12 000
Revenue per Share
0.15
Revenue Growth 3 Years
61.73
Revenue Growth 5 Years
-31.76
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.60-0.5410.00
Q02 2018-0.53-0.4220.75
Q01 2018-0.54-0.499.26
Q04 2017-0.56-0.527.14
Q03 2017-0.65-0.633.08
Q02 2017-0.56-0.4814.29
Q01 2017-0.63-0.5611.11
Q04 2016-0.64-0.606.25
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.492.00Positive
12/2018 FY-1.930.00-
3/2019 QR-0.52-6.12Negative
12/2019 FY-2.23-0.90Negative
Next Report Date12th Mar 2019
Estimated EPS Next Report-0.49
Estimates Count8
EPS Growth Next 5 Years %38.00
Volume Overview
Volume419 854
Shares Outstanding (in ths.)79 168
Trades Count2 219
Dollar Volume4 168 564
Avg. Volume949 042
Avg. Weekly Volume463 233
Avg. Monthly Volume680 668
Avg. Quarterly Volume870 083

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

25%75%

Bearish Bullish

60%40%

Bearish Bullish

67%33%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (87.50 %)
8 (88.89 %)
7 (77.78 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (12.50 %)
1 (11.11 %)
2 (22.22 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.25
Strong Buy
1.22
Strong Buy
1.44

There are no comments yet.

News